Stay updated on Revvity Press Releases
Sign up to get notified when there's something new on the Revvity Press Releases page.

Latest updates to the Revvity Press Releases page
- CheckyesterdayChange DetectedThe latest press release now announces Revvity’s third-quarter 2026 earnings call, scheduled for November 3, replacing the earlier notice for its second-quarter call on August 4.SummaryDifference2%

- Check8 days agoChange DetectedAdds a new September 24, 2026 press release announcing Revvity's IVDR-certified autoantibody detection solution for early detection of Type 1 diabetes, featuring a fully automated, multiplex system for population-wide screening. Removes July 1, 2026 entries about the MCP connector extending Signals AI and about Anthropic Claude integration, as part of content refresh.SummaryDifference2%

- Check15 days agoChange DetectedNo textual additions or deletions are present for the Newsroom page. The page content remains unchanged according to the provided data.SummaryDifference1%

- Check22 days agoChange DetectedRevvity announces its planned acquisition of Human Cell Design to advance human-relevant cell models for metabolic disease drug discovery, signaling a strategic expansion in life sciences tools. The Newsroom also removes a previously listed Signals AI press release from June 22, 2026.SummaryDifference2%

- Check29 days agoChange DetectedNo textual updates are recorded for the Newsroom page. The page content appears unchanged in the supplied change data.SummaryDifference0.4%

- Check44 days agoChange DetectedThe Newsroom page content remains the same, with no new items added or existing items removed.SummaryDifference0.2%

Stay in the know with updates to Revvity Press Releases
Enter your email address, and we'll notify you when there's something new on the Revvity Press Releases page.